Sawida, Felisida .
HRN: 05-67-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2023
CEFUROXIME 1.5GM (VIAL)
05/24/2023
05/25/2023
IV
1.5gms
On Call To OR
For D&C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes